Medtronic plc (ETR:2M6)

Market Cap	110.43B
Revenue (ttm)	31.58B
Net Income (ttm)	4.05B
Shares Out	n/a
EPS (ttm)	3.11
PE Ratio	27.26
Forward PE	n/a
Dividend	2.59 (3.01%)
Ex-Dividend Date	Dec 27, 2024

Volume	4,932
Average Volume	1,574
Open	83.71
Previous Close	83.65
Day's Range	83.55 - 87.00
52-Week Range	70.10 - 90.14
Beta	0.86
RSI	52.32
Earnings Date	Feb 18, 2025

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 2M6

Financial Performance

In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.

Financial numbers in USD